US Drug Recall Register
Class I · High risk Terminated Initiated Sep 17, 2018 (8 years ago)

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed…

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."

What was recalled

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.

Recalling firm
Endo Pharmaceuticals, Inc.
NDC code
52244-449-10
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0009-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methocarbamol recalls

See all